Document Actions

Drug Utilization Review Board Meeting Agendas

last modified 05/15/2012 - 07:33 AM

resolveuid/295ea1eb1aa346296d3dd79b26265abc

2012 AGENDAS

May 15, 2012

Second Generation (Atypical) Antipsychotics
Rifamycins

April 10, 2012

Osteoporosis Treatments
Insulins
Thiazolidinediones
Oral Antifungals

February 21, 2012

Oral Antifungals
Hepatitis C Antivirals
Interferons
Pegylated Interferons

January 10, 2012

Dipeptidyl Peptidase Inhibitors
Amylinomimetics
Incretin Mimetics
Growth Hormone
MS Biologic Response Modifiers
Potassium Channel Blockers
Opthalmic Antibiotics
Opthalmic Antihistamines
Opthalmic NSAIDS
Vaginal Antibiotics
Vaginal Antifungals

2011 AGENDAS

December 06, 2011

First Generation Cephalosporins
Second Generation Cephalosporins
Third Generation Cephalosporins
Ketolides
Macrolides
Penicillins
Glycopeptides
Tetracyclines
Oxazolidinones

October 25, 2011

Hepatitis C Protease Inhibitors
Omega-3 Acid Ehtyl Esters
Niacin Derivatives
HMG CoA Reducrase Inhibitors
Fibric Acid Derivatives
Cholesterol Absorption Inhibitors
Bile Acid Sequestrants

September 13, 2011

Angiotensin-converting enzyme (ACE) inhihibitors - single entity agents
Angiotensin-converting enzyme (ACE) inhibitors - combination products
Angiotensin II receptor blockers (ARBS) - single entity agents
Angiotensin II receptor blockers (ARBS) - combination products
Beta-adrenergic blocking agents - single entity agents
Beta-adrenergic blocking agents - diruetic combination products
Calcium channel blocking agents - dihydropyridines
Calcium channel blocking agents - non-dihydropyridines
Renin inhibitors
Weight-loss therapy
Cardiotonic agents
Direct vasodilators - combination products
Miscellaneous cardiac drugs
Nitrates and nitrites

July 19, 2011

Platelet Inhibitors
Intermittent Claudication Agents
Injectable Anticoagulants
Hemostatic Agents
Erythropoiesis Stimulating Agents
Pulmonary Arterial Hypertension Agents

05/17/11 Class Reviews

Smoking Cessation
Long Acting Narcotics
Immunomodulators
Leukotriene Modifiers

May 17, 2011

4/5/11 Class Reviews

Second generation anithistamines
Beta-agonists anticholinergic combination products
Beta-agonists single entity agents
ICS single entity agents
ICS LABA combinatin products
Inhaled antimuscarincs
Inhaled cystic fibrosis agents
Intranasal antihistamines
Intranasal corticosteroids
Omalizumab(Xolair)

April 5, 2011

February 22, 2011

2/22/11 Class Reviews

Pegylated Interferons
Dipeptidyl Peptidase inhibitors
Quinolones
Proton Pump Inhibitors single entity

2010 AGENDAS

December 7, 2010

12/7/10 Class Reviews:

Leukotrine Modifiers

October 26, 2010
September 14, 2010
June 29, 2010
May 18, 2010
April 13, 2010
February 9, 2010
January 12, 2010

2009 AGENDAS

December 8, 2009
November 10, 2009
October 13, 2009
September 8, 2009
June 9, 2009
May 12, 2009
March 24, 2009

February 10, 2009
January 13, 2009

2008 AGENDAS

CANCELLED December 9, 2008

Wednesday,* November 12, 2008
October 14, 2008
September 9, 2008
June 10, 2008
May 13, 2008
April 1, 2008
February 12, 2008
January 15, 2008

2007 AGENDAS

December 11, 2007
November 13, 2007
October 9, 2007
September 11,2007
June 12, 2007
May 8, 2007
April 3, 2007
February 13, 2007
January 16, 2007

2006 AGENDAS

December 12, 2006
June 13, 2006

Department of Vermont Health Access

Agency of Human Services

Sections

Document Actions

Drug Utilization Review Board Meeting Agendas

Personal tools

State of Vermont Web Policies and Copyright

A Vermont Government Website